Press Releases about Oncology Pharma Inc
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
Oncology Pharma Reports on Progress with Ribera Solutions
March 02, 2022
From Oncology Pharma Inc.
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
Oncology Pharma Expands on Feasibility Studies and Data
February 17, 2022
From Oncology Pharma Inc.
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
Oncology Pharma Meeting Towards Future Developments
December 17, 2021
From Oncology Pharma Inc.
Via AccessWire
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
Oncology Pharma Year End Review and Outlook
December 09, 2021
From Oncology Pharma Inc.
Via AccessWire
Topics
Intellectual Property
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
Oncology Pharma Research and Vision
November 30, 2021
From Oncology Pharma Inc.
Via AccessWire
Topics
Intellectual Property
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress
October 27, 2021
From Oncology Pharma Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
Oncology Pharma, Inc. Update on PCAOB Audit Selection Process and License Agreement
October 12, 2021
From Oncology Pharma Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Oncology Pharma Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.